The RANK-L/RANK axis has also been implicated in mammary oncogenesis and in epithelial-to-mesenchymal transition, and pharmacological RANK-L inhibition was shown to reduce breast cancer formation in mouse models47–50. Here, TNFRSF11A is linked to breast carcinoma.